Literature DB >> 8743211

Thrombocytopenia in horses: 35 cases (1989-1994).

D C Sellon1, J Levine, E Millikin, K Palmer, C Grindem, P Covington.   

Abstract

The records of 3,952 equine patients presenting to the Veterinary Teaching Hospital at North Carolina State University College of Veterinary Medicine were evaluated to determine risk factors associated with thrombocytopenia. Of 2,346 horses from which a CBC was obtained, 35 (1.49%) were thrombocytopenic (platelet count < 75,000/microL). A reference population of 189 horses with normal platelet counts (75,000 to 300,000/microL) was also studied. Standardbred horses were at increased risk for thrombocytopenia, but age and gender were not identified as significant risk factors. Horses with infectious or inflammatory diseases were at increased risk for thrombocytopenia. The potential association of clinical and clinicopathologic factors with thrombocytopenia were assessed by reviewing a series of multiple logistic regression models. Clinical and clinicopathologic variables significantly associated with thrombocytopenia in the final model included increased PCV, increased band neutrophil count, increased total WBC, and decreased plasma protein concentration. Increased mature neutrophil count was associated with normal platelet counts. Thrombocytopenic horses were significantly more likely to die to be euthanized than were horses with normal platelet counts.

Entities:  

Mesh:

Year:  1996        PMID: 8743211     DOI: 10.1111/j.1939-1676.1996.tb02044.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  3 in total

1.  Assessment of Equine Autoimmune Thrombocytopenia (EAT) by flow cytometry.

Authors:  Rafael Nunez; M Alice Gomes-Keller; Colin Schwarzwald; Karsten Feige
Journal:  BMC Blood Disord       Date:  2001

2.  Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses.

Authors:  Sarah Y Broeckx; Bert Seys; Marc Suls; Aurélie Vandenberghe; Tom Mariën; Edouard Adriaensen; Jeroen Declercq; Lore Van Hecke; Gabriele Braun; Klaus Hellmann; Jan H Spaas
Journal:  Stem Cells Dev       Date:  2019-02-13       Impact factor: 3.272

3.  Equine platelet concentrate preparation and validation.

Authors:  Rana Bozorgmanesh; K Gary Magdesian; Julie W Sutton-Burges; Sean D Owens; Fern Tablin
Journal:  J Vet Intern Med       Date:  2019-03-13       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.